Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update
at the 35th Annual J.P. Morgan Healthcare Conference on
Monday, January 9, 2017 at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern
Time at the Westin St. Francis Hotel in San Francisco. The presentation
will be followed by a question and answer session that will begin at
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
A live webcast of Ironwood's presentation and the question and answer
session will be accessible through the Investors section of the
company's website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start time to ensure adequate time
for any software downloads that may be required. A replay of the webcast
will be available on Ironwood's website for 14 days following the
About Ironwood Pharmaceuticals
Pharmaceuticals (NASDAQ: IRWD) is a commercial biotechnology company
focused on creating medicines that make a difference for patients,
building value for our fellow shareholders, and empowering our
passionate team. We are advancing a pipeline of innovative medicines in
areas of significant unmet need, including irritable bowel syndrome with
constipation (IBS-C)/chronic idiopathic constipation (CIC), uncontrolled
gout, refractory gastroesophageal reflux disease, and vascular and
fibrotic diseases. We discovered, developed and are commercializing
linaclotide, the U.S. branded prescription market leader in the
IBS-C/CIC category, and we are applying our proven R&D and commercial
capabilities to advance multiple internally-developed and
externally-accessed product opportunities. Ironwood was founded in 1998
and is headquartered in Cambridge, Mass. For more information, please
visit www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely posted
in both these locations.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170103006224/en/
Ironwood Pharmaceuticals, Inc.
Director, Corporate Communications
Meredith Kaya, 617-374-5082
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top